Cocrystal Pharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $136 |
Gross Profit | -13 | -21 | -1,360 | -28 |
EBITDA | -2,036 | -2,087 | -2,316 | -3,238 |
EBIT | -2,049 | -2,108 | -2,341 | -3,266 |
Net Income | -2,049 | -2,055 | -2,301 | -3,266 |
Net Change In Cash | 0 | 0 | 0 | 136 |
Free Cash Flow | -1,561 | -2,155 | -2,939 | -3,160 |
Cash | 7,729 | 4,766 | 6,921 | 9,860 |
Basic Shares | 10,991 | 10,174 | 10,174 | 10,174 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $5,427 |
Gross Profit | -12,537 | -15,169 | -12,392 | -8,794 |
EBITDA | -17,752 | -20,970 | -17,952 | -14,031 |
EBIT | -17,878 | -21,159 | -18,137 | -14,221 |
Net Income | -17,504 | -17,984 | -38,837 | -14,185 |
Net Change In Cash | 0 | 0 | 0 | 5,427 |
Free Cash Flow | -16,493 | -14,784 | -21,509 | -12,771 |
Cash | 9,860 | 26,353 | 37,144 | 58,705 |
Basic Shares | 10,174 | 9,651 | 8,143 | 7,689 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.19 |
2025-06-30 | -$0.20 |
2025-03-31 | -$0.32 |
2024-12-31 | -$0.32 |
